Pharmacology, clinical efficacy and safety of terlipressin in esophageal varices bleeding, septic shock and hepatorenal syndrome.
about
Terlipressin therapy for reversal of type 1 hepatorenal syndrome: a meta-analysis of randomized controlled trials.Recent advances in our understanding of hepatorenal syndrome.Impact of terlipressin infusion during and after live donor liver transplantation on incidence of acute kidney injury and neutrophil gelatinase-associated lipocalin serum levels: A randomized controlled trial.Design, synthesis and structure-activity relationship of new arginine vasopressin analogues containing proline derivatives in position 2.In vitro binding and receptor-mediated activity of terlipressin at vasopressin receptors V1 and V2.
P2860
Pharmacology, clinical efficacy and safety of terlipressin in esophageal varices bleeding, septic shock and hepatorenal syndrome.
description
2007 nî lūn-bûn
@nan
2007 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Pharmacology, clinical efficac ...... hock and hepatorenal syndrome.
@ast
Pharmacology, clinical efficac ...... hock and hepatorenal syndrome.
@en
Pharmacology, clinical efficac ...... hock and hepatorenal syndrome.
@nl
type
label
Pharmacology, clinical efficac ...... hock and hepatorenal syndrome.
@ast
Pharmacology, clinical efficac ...... hock and hepatorenal syndrome.
@en
Pharmacology, clinical efficac ...... hock and hepatorenal syndrome.
@nl
prefLabel
Pharmacology, clinical efficac ...... hock and hepatorenal syndrome.
@ast
Pharmacology, clinical efficac ...... hock and hepatorenal syndrome.
@en
Pharmacology, clinical efficac ...... hock and hepatorenal syndrome.
@nl
P2860
P356
P1476
Pharmacology, clinical efficac ...... shock and hepatorenal syndrome
@en
P2093
Christoph E Broelsch
Fuat H Saner
P2860
P304
P356
10.1586/17474124.1.2.207
P577
2007-12-01T00:00:00Z